Insulin glargine and lixisenatide and Tenecteplase Intravenous
Determining the interaction of Insulin glargine and lixisenatide and Tenecteplase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: tenecteplase
Brand name: TNKase
Synonyms: Tenecteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Tenex
- Insulin glargine and lixisenatide-Teniposide
- Insulin glargine and lixisenatide-Teniposide Injection
- Insulin glargine and lixisenatide-Teniposide Intravenous
- Insulin glargine and lixisenatide-Tenivac
- Insulin glargine and lixisenatide-Tenivac (Td) Td
- Tenecteplase Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Tenecteplase Intravenous-Insulin glargine, recombinant Subcutaneous
- Tenecteplase Intravenous-Insulin glulisine
- Tenecteplase Intravenous-Insulin Glulisine (Cartridges and Pens)
- Tenecteplase Intravenous-Insulin Glulisine (Vials)
- Tenecteplase Intravenous-Insulin glulisine Subcutaneous